- Home
- HUMA vs INFU Comparison
HUMA vs INFU Comparison
Compare HUMA & INFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HUMA | INFU |
|---|---|---|
| Founded | 2004 | 2005 |
| Country | United States | United States |
| Employees | 184 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 191.4M | 197.0M |
| IPO Year | N/A | 2005 |
Fundamental Metrics
Financial Performance| Metric | HUMA | INFU |
|---|---|---|
| Price | $0.72 | $12.26 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 2 |
| Target Price | $6.19 | ★ $15.00 |
| AVG Volume (30 Days) | ★ 5.0M | 160.2K |
| Earning Date | 05-15-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 181.82 |
| EPS | N/A | ★ 0.20 |
| Revenue | N/A | ★ $143,436,000.00 |
| Revenue This Year | $444.16 | $3.20 |
| Revenue Next Year | $248.39 | $7.31 |
| P/E Ratio | ★ N/A | $59.35 |
| Revenue Growth | N/A | ★ 6.36 |
| 52 Week Low | $0.55 | $7.29 |
| 52 Week High | $2.55 | $12.97 |
Technical Indicators
Market Signals| Indicator | HUMA | INFU |
|---|---|---|
| Relative Strength Index (RSI) | 48.35 | 69.23 |
| Support Level | $0.63 | $8.57 |
| Resistance Level | $0.87 | N/A |
| Average True Range (ATR) | 0.05 | 0.62 |
| MACD | 0.02 | 0.32 |
| Stochastic Oscillator | 81.13 | 74.30 |
Price Performance
Historical ComparisonAbout HUMA Humacyte Inc.
Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.
About INFU InfuSystems Holdings Inc.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.